New Device for More Protection in Carotid Artery Stenting

This new “Paladin” system for post-dilation during carotid artery stenting was safe and may effectively reduce the number of particles that reach the brain, with a subsequent decreased risk for peri-procedural stroke.

Nuevo dispositivo para tener mayor protección en la angioplastia carotídeaThis study evaluated the safety and efficacy of the Paladin System, a novel post-dilation balloon with an integrated distal protection filter designed to increase safety during one of the most critical procedural moments: post-stent dilation.

 

While the risk of major adverse events during stenting is equivalent to that during endarterectomy, the risk of minor stroke, much of which occurs during post-stent dilation, remains higher with carotid artery stenting.

 

This study enrolled a total of 106 patients in 5 centers in Germany; the primary endpoint was all-cause death, acute myocardial infarction, and stroke within 30 days from the procedure.


Read also: Effect of More Expedited Carotid Intervention on Recurrent Events.


Among cohort patients, 30 subjects were assessed through diffusion-weighted magnetic resonance imaging before and after the procedure, in search for new lesions.

 

There was a retrospective analysis comparing outcomes with historical controls.

 

Procedural and device success rates were 100%. The combined event (death, infarction, and stroke) rates at discharge and at 30 days were 0% and 1%, respectively.


Read also: Safety of Early Carotid Artery Stenting in Symptomatic Patients.


The single adverse event was a stroke at day 12 that is believed to be unrelated to the device or the procedure.

 

Diffusion-weighted magnetic resonance imaging found new lesions in 36.7% of patients, and 30% of such lesions were ipsilateral.

 

Debris was present in all filters, and 90% of these particles were <100 μm.

 

Conclusion

The Paladin System for post-stent dilation with greater protection during carotid artery stenting is effective and may reduce the number of embolic particles, with a subsequent reduction in peri-procedural stroke.

 

Original title: Double Filtration During Carotid Artery Stenting Using a Novel Post-Dilation Balloon with Integrated Embolic Protection.

Reference: Ralf Langhoff et al. J Am Coll Cardiol Intv 2019;12:395-403.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...